If you enjoy this content, please share it with a colleague
ViewRay Incorporated
RELATED CONTENT
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of magnetic ...
Carri Glide-Hurst, Ph.D., and Benjamin Movsas, M.D., discuss Henry Ford Hospital's involvement in a national clinical ...
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's MRIdian Linac. The MRIdian Linac is the first system to combine magnetic resonance imaging (MRI) guidance and linear accelerator radiation delivery. These treatments mark the first in Turkey using MRI-guided radiation therapy.
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St ...
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac radiotherapy system. Designed to improve tumor and soft tissue visualization, these enhancements to MRIdian's SmartVision MR image guidance are expected to further improve the precision by which radiation is delivered to treat cancer.
March 21, 2018 — ViewRay Inc. recently announced that the company received Shonin approval from the Japanese Ministry of ...
October 25, 2017 — ViewRay Inc. announced outcomes data presented during the recent 2017 Annual Meeting of the American ...
August 7, 2017 — ViewRay Inc. announced that several presentations of early clinical experience with its MRIdian Linac ...
July 25, 2017 — ViewRay Inc. announced recently that the first cancer patients have been treated using the company's ...
The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced radiation therapy with the ViewRay MRIdian Linac system. The system uses a U.S. Food and Drug Administration (FDA)-approved real-time magnetic resonance imaging (MRI) and linear accelerator delivery for more precise and accurate radiation treatment.